Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Diseases × Acetaminophen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 5 Neoplasms 2 Multiple Myeloma 2 Cancer Pain 2 Squamous Cell Carcinoma of Head and Neck 1 Pain, Postoperative 1 Paget Disease, Extramammary 1 Ovarian Neoplasms 1 Lymphoma 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Agnosia 1

Interventions

ribociclib 2 palbociclib 2 Gonadotropin-Releasing Hormone 2 Doxorubicin 2 Docetaxel 2 Anastrozole 2 AZD9833 2 trastuzumab deruxtecan 1 taxane 1 pertuzumab 1 pegfilgrastim 1 ipatasertib 1 atezolizumab 1 abemaciclib 1 Trastuzumab 1 Sodium Chloride 1 Paclitaxel 1 Letrozole 1 Ibuprofen 1 Fulvestrant 1 Drug Therapy 1 Denosumab 1 Cyclophosphamide 1 Codeine 1 Capecitabine 1 Botulinum Toxins, Type A 1 Bevacizumab 1 Acetaminophen 1 2,2'-dithiodiethanesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡